We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
(+18%)
Cap. Flow
+$342M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$163M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$137M |
| 3 |
Repligen
RGEN
|
+$104M |
| 4 |
Biogen
BIIB
|
+$104M |
| 5 |
Zoetis
ZTS
|
+$91.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$173M |
| 2 |
Agilent Technologies
A
|
+$137M |
| 3 |
Fidelity National Information Services
FIS
|
+$86.2M |
| 4 |
Adobe
ADBE
|
+$76.2M |
| 5 |
Keurig Dr Pepper
KDP
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.24% |
| 2 | Consumer Discretionary | 12.89% |
| 3 | Financials | 10.77% |
| 4 | Technology | 9.62% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Kiniksa Pharmaceuticals
KNSA
$4.89B
| $1.38M | 0.01% |
78,352
-69,951
| -47% | -$1.23M |
|
1077
AB InBev
BUD
$156B
| $1.38M | 0.01% |
19,773
+10,382
| +111% | +$657K |
|
1078
Black Diamond Therapeutics
BDTX
$99.1M
| $1.38M | 0.01% |
+43,081
| New | +$1.42M |
|
1079
Lindsay Corp
LNN
$1.17B
| $1.38M | 0.01% |
10,725
+1,702
| +19% | +$194K |
|
|
UPH
1080
DELISTED
UpHealth, Inc.
UPH
| $1.37M | 0.01% |
+12,538
| New | +$1.29M |
|
|
HMHC
1081
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $1.37M | 0.01% |
+410,627
| New | +$1.22M |
|
1082
MiMedx Group
MDXG
$635M
| $1.37M | 0.01% |
+150,447
| New | +$1.08M |
|
|
INOV
1083
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $1.35M | 0.01% |
74,446
-47,154
| -39% | -$1.01M |
|
1084
C3.ai
AI
$1.37B
| $1.34M | 0.01% |
+9,694
| New | +$1.3M |
|
1085
Qorvo
QRVO
$7.92B
| $1.34M | 0.01% |
8,081
-158,100
| -95% | -$23.3M |
|
1086
Castle Biosciences
CSTL
$741M
| $1.34M | 0.01% |
19,995
+15,468
| +342% | +$838K |
|
1087
Eastern Bankshares
EBC
$5.29B
| $1.34M | 0.01% |
+82,219
| New | +$1.17M |
|
1088
Ormat Technologies
ORA
$6.28B
| $1.34M | 0.01% |
14,650
-112,224
| -88% | -$8.5M |
|
1089
WisdomTree
WT
$3.01B
| $1.34M | 0.01% |
250,599
-654,771
| -72% | -$2.82M |
|
1090
Tenet Healthcare
THC
$21B
| $1.34M | 0.01% |
+33,525
| New | +$1.08M |
|
|
DISH
1091
DELISTED
DISH Network Corp.
DISH
| $1.33M | 0.01% |
41,302
-524,978
| -93% | -$16.2M |
|
1092
Abercrombie & Fitch
ANF
$4.41B
| $1.33M | 0.01% |
65,279
+53,554
| +457% | +$982K |
|
|
ASPL.WS
1093
CALL
DELISTED
Aspirational Consumer Lifestyle Corp. Redeemable Warrants, each whole warrant exercisable for one Cl
ASPL.WS
| $1.33M | 0.01% |
+133,329
| New | +$134K |
|
1094
American Electric Power
AEP
$72.7B
| $1.33M | 0.01% |
+15,925
| New | +$1.38M |
|
1095
National Vision
EYE
$1.66B
| $1.32M | 0.01% |
+29,168
| New | +$1.27M |
|
1096
Elanco Animal Health
ELAN
$12.7B
| $1.32M | 0.01% |
+42,998
| New | +$1.31M |
|
1097
Columbus McKinnon
CMCO
$472M
| $1.32M | 0.01% |
34,284
-20,671
| -38% | -$778K |
|
|
ADVWW
1098
CALL
DELISTED
Advantage Solutions Warrant
ADVWW
| $1.32M | 0.01% |
+99,999
| New | +$198K |
|
1099
United Natural Foods
UNFI
$2.97B
| $1.31M | 0.01% |
82,330
+34,320
| +71% | +$574K |
|
1100
Malibu Boats
MBUU
$557M
| $1.31M | 0.01% |
20,996
-69,065
| -77% | -$3.99M |
|
Similar funds
Marshall Wace's Q4 2020 Portfolio in Review
As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
- Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
- Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
- Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
- Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
- Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
- Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.
Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.